TodaysHealthyNews.com

TenX Biopharma Reinitiates Enrollment In Pivotal Phase III, CTCL Trial

Wed, 08 Sep 2010 21:45:41 +0000

TenX Biopharma, Inc. announced that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients. The trial enrollment was suspended in October 2008 while Genmab (CO:GEN) was seeking a out-license agreement to further develop the compound…

Researchers Identify Protein That Fights West Nile Virus

Wed, 08 Sep 2010 21:29:22 +0000

Yale and McGill University scientists have identified a protein that is critical in fighting mosquito-borne West Nile Virus in mice. This finding could have therapeutic implications for controlling the potentially deadly virus in humans. The study appears in the Advance Online Publication of Nature Immunology…

AHRQ Releases New Spanish Language Guides For Patients

Wed, 08 Sep 2010 21:21:41 +0000

HHS’ Agency for Healthcare Research and Quality today released a series of free evidence-based guides designed to help Spanish speakers understand and compare the risks, benefits and side effects of treatments for eight health conditions. The guides provide valuable information that patients can use in talking with their clinicians…

New Research Confirms Skin Cancer Prevention One Of The Nation’s Best Health Investments

Wed, 08 Sep 2010 21:21:29 +0000

The Australian Government should act on comprehensive new research and run an intensive SunSmart campaign to reduce Australia’s unacceptable skin cancer burden, Cancer Council Australia said today…

Explaining An Important Genetic Cardiovascular Risk Factor

Wed, 08 Sep 2010 21:19:42 +0000

New findings reported in the September issue of Cell Metabolism, a Cell Press publication, appear to explain why people who carry specific and common versions of a single gene are more likely to have high cholesterol and to suffer a heart attack. Studies in mice show that the gene, known as sortilin (SORT1), controls the release of LDL (a.k.a…

NHS Choices: Six Warning Signs Of Cancer

Wed, 08 Sep 2010 20:54:28 +0000

More than 1/3 people in the UK will develop some form of cancer during their lifetime. The good news is that some cancers can be cured if detected early enough. The key is to be aware of unexplained changes to your body, and to know the common signs and symptoms of cancer…

Using Lower-Dose Heparin During Percutaneous Coronary Intervention Does Not Appear To Reduce The Risk Of Major Bleeding

Wed, 08 Sep 2010 20:44:24 +0000

Patients with acute coronary syndromes initially treated with the anticoagulant fondaparinux who underwent a coronary procedure (such as balloon angioplasty) and received a lower dose of the anticoagulant heparin during the procedure did not have a reduced rate of major bleeding and vascular access site complications, according to a study that will appear in the September 22 issue of JAMA…

Associatiion Between Regular Statin Use And A Reduced Risk Of Developing Rheumatoid Arthritis

Wed, 08 Sep 2010 19:35:05 +0000

There is an association between taking statins (lipid lowering drugs), and reduced risk of developing the chronic inflammatory disease, rheumatoid arthritis. These are the findings of a study by Gabriel Chodick and colleagues, published in this week’s PLoS Medicine. The researchers conducted a retrospective cohort study among the 1…

To Reach, Perchance To Kill The Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That ‘Sea Of Troubles’

Wed, 08 Sep 2010 18:43:03 +0000

Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, reports the publication of a landmark paper in clinical oncology. Following up on its advanced U.S…

The Medal Of The Chemical Research Society Of India Awarded To Penn State Chemist Ayusman Sen

Wed, 08 Sep 2010 18:21:07 +0000

Ayusman Sen, Distinguished Professor of Chemistry at Penn State University, has been honored with the Chemical Research Society of India (CRSI) Medal. Sen is only the second recipient of the medal, which is awarded exclusively to outstanding chemists of Indian origin who work outside of India…